Analysis of US Marketed Artemisinin Supplements for Use in Dogs

Documenti analoghi

• Response to Correspondence on ‘Analysis of US Marketed Artemisinin Supplements for Use in Dogs’
  di: Alyssa R. Berman, et al.
  Pubblicazione: (2024)
• Correspondence on Analysis of US Marketed Artemisinin Supplements for Use in Dogs
  di: Hinpetch Daungsupawong, et al.
  Pubblicazione: (2024)
• Population Pharmacokinetics of Sildenafil in Dogs With Naturally Occurring Pulmonary Hypertension
  di: Mariko Yata, et al.
  Pubblicazione: (2026)
• Routine Doses of Enrofloxacin Achieve Pharmacodynamic Target Likely to Treat Susceptible and Susceptible Dose‐Dependent Bacterial Infections in Critically Ill Dogs
  di: Robert Goggs, et al.
  Pubblicazione: (2025)
• Perceptions of Medications and Supplements by U.S. Dog‐Interested Members of the Public and Final‐Year Veterinary Students
  di: Sidonie T. Gallinger, et al.
  Pubblicazione: (2026)